Clinical Trial Update: A Single, High-Dose Azithromycin Extended Release (60 mg/kg) Compared With 10 Days of High-Dose Amoxicillin Clavulanate in Children With Ear Infections at High Risk of Persistent/Recurrent Ear Infections [Phase 3]

View source ↗

Summary

Phase 3 trial comparing a single high-dose azithromycin extended-release regimen with 10 days of high-dose amoxicillin-clavulanate in children with acute otitis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Otitis Media

Drugs mentioned

• Augmentin (amoxicillin/clavulanate)
• Azithromycin extended-release (60 mg/kg single dose) (azithromycin)

Snippet

Sponsor: Pfizer | Conditions: Acute Otitis Media | Phase 3 | Status: COMPLETED